Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas

Journal of Endocrinological Investigation

Volumn 32, Issue 11, 2009, Pages 913-916

  Yilmaz, H ^a   Tutuncu N B ^a   Sahin M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Adrenal incidentaloma; Insulin resistance; Subclinical cushing's syndrome

Indexed keywords

ALDOSTERONE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METADRENALIN; NORMETADRENALIN; RENIN; TRIACYLGLYCEROL; VANILMANDELIC ACID;

ADRENAL FUNCTION; ADRENAL INCIDENTALOMA; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE VARIABILITY; BODY FAT DISTRIBUTION; BODY MASS; CANCER PATIENT; CATECHOLAMINE URINE LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLASMA RENIN ACTIVITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR VOLUME; URINE LEVEL; WAIST HIP RATIO;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADULT; AGED; ALDOSTERONE; CUSHING SYNDROME; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; INCIDENTAL FINDINGS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; RENIN;

EID: 77649228667     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03345772     Document Type: Article

References (27)

1. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR The clinically inapperant adrenal mass: update in diagnosis and management. Endocr Rev 2004, 25: 309-40.
2. Libè R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. Europen J of Endocrinol 2002, 147: 489-94.
3. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995, 16: 460-84.
4. Gross MD, Shapiro B. Clinically silent adrenal masses. J Clinic Endocrinol Metab 1993, 77: 885-8.
5. Bülow B, Jansson S, Juhlin C. Adrenal incidentaloma- follow-up results from a Swedish prospective study. Eur J Endocrinol 2006, 154: 419-23.
6. Grossrubatscher E, Vignati F, Possa M, Lohi P. The natural history of incidentally discovered adrenocortical adenomas: A retrospective evaluation. J Endocrinol Invest 2001, 24: 846-55.
7. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clinic Endocrinol Metab 1999, 84: 520-6.
8. Reincke M Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000, 29: 43-56.
9. Linos DA. Management approaches to adrenal incidentalomas(adrenalomas). A view from Athens, Greece. Endocrinol Metab Clin North Am 2000, 29: 141-57.
10. Vilar L, Freitas Mda C, Canadas V, et al. Adrenal incidentalomas: Diagnostic evaluation and long-term follow-up. Endocr Pract 2008, 14: 269-78.
11. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapperant adrenal mass ("incidentaloma"). Ann Intern Med 2003, 138: 424-9.
12. Mantero F, Arnaldi G 2000 Management approaches to adrenal incidentalomas. Endocrinol Metab Clin North Am 29: 107-25.
13. Sirén J, Tervahartiala P, Sivula A, Haapiainen R. Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 2000, 24: 579-82.
14. Sirén JE, Haapiainen RK, Huikuri KT, Sivula AH. Incidentalomas of the adrenal gland: 36 operated patients and review of the literature. World J Surg 1993, 17: 634-9.
15. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clinic Endocrinol Metab 2000, 85: 637-44.
16. Bernini GP, Moretti A, Oriandini C, Bardini M, Taurino C, Salvetti A. Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. British J Cancer 2005, 92: 1104-9.
17. Jockenhövel F, Kuck W, Hauffa B, et al. Conservative and surgical management of incidentally discovered adrenal tumors. J Endocrinol Invest 1992, 15: 331-7.
18. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevelance and natural history of adrenal incidentalomas. Eur J Endocrinol 2003, 149: 273-85.
19. Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical features. J Clin Endocrinol Metab 2000, 85: 1440-8.
20. Valli N, Catargi B, Ronci N, et al Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Europen J Endocrinol 2001, 144: 401-8.
21. Eldeiry LS, Garber JR Adrenal incidentalomas, 2003 to 2005: Experience after publication of the National Institutes of Health Consensus Statement. Endocr Pract 2008, 14: 279-84.
22. Tsagarakis S, Vassiliadi D, Thalassinos N. Endogenous subclinical hypercortisolism: Diagnostic uncertanities and clinical implications. J Endocrinol Invest 2006, 29: 471-82.
23. Garrapa G, Pantanetti P, Arnaldi G, Mantero F, Faloia E. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clinic Endocrinol Metab 2001, 86: 5301-6.
24. Terzolo M, Pia A, Alì A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clinic Endocrinol Metab 2002, 87: 998-1003.
25. Reincke M, Fassnacht M, Väth S, Mora P, Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocrine Research 1996, 22: 757-61.
26. Singh PK, Bush HN. Adrenal insidentaloma: evaluation and management. J Clin Pathol 2008, 61: 1168-73.
27. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's Syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93: 1526-40.